Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
5
63%
Ph phase_2
1
13%
Ph phase_3
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(4)
Terminated(1)
Other(3)

Detailed Status

Completed4
unknown3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (14.3%)
Phase 31 (14.3%)
N/A5 (71.4%)

Trials by Status

completed450%
unknown338%
terminated113%

Recent Activity

0 active trials
Showing 5 of 8
completed

PRedicting OutcomeS in Preterm nEonates With thromboCyTopenia

NCT06043050
completedphase_3

Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation

NCT04704869
completednot_applicable

Patient Blood Management for Massive Obstetric Hemorrhage

NCT03784794
terminatednot_applicable

Safety of Platelet Transfusion in Patients on Antiplatelet Therapy With Traumatic Head Injury

NCT01810276
unknownnot_applicable

Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis

NCT02721940
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06043050

PRedicting OutcomeS in Preterm nEonates With thromboCyTopenia

Completed
NCT04704869Phase 3

Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation

Completed
NCT03784794Not Applicable

Patient Blood Management for Massive Obstetric Hemorrhage

Completed
NCT01810276Not Applicable

Safety of Platelet Transfusion in Patients on Antiplatelet Therapy With Traumatic Head Injury

Terminated
NCT02721940Not Applicable

Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis

Unknown
NCT01534117Not Applicable

Platelet Function Analysis in Head Trauma: ASA/Plavix

Completed
NCT00699621Not Applicable

Platelet Transfusion in Acute Intracerebral Hemorrhage

Unknown
NCT01135862Phase 2

Platelet Administration To Patients With Traumatic Brain Injury Who Were Treated With Aspirin

Unknown

All 8 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
8